Claim: The HSP90AB1 are long charged domains which contains the Azithromycin domain that binds to a CTD and the inhibition of HSP90 by amino acids is based on their binding to the CTD.
Evidence: Inhibition of HSP90 activity by geldanamycin derivatives is based on their binding to the ATP binding site.